HA
PFE icon

Huntleigh Advisors’s Pfizer PFE Stock Holding History

Huntleigh Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
66,578
+1,351
+2% +$35.3K 0.22% 99
2026
Q1 		$1.83M Buy
65,227
+2,740
+4% +$72.9K 0.31% 75
2025
Q4 		$1.56M Buy
62,487
+764
+1% +$19.3K 0.26% 91
2025
Q3 		$1.57M Sell
61,723
-3,412
-5% -$84.2K 0.27% 94
2025
Q2 		$1.58M Buy
65,135
+6,588
+11% +$154K 0.3% 83
2025
Q1 		$1.48M Buy
58,547
+713
+1% +$18.7K 0.25% 80
2024
Q4 		$1.53M Buy
+57,834
New +$1.57M 0.33% 71

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Huntleigh Advisors's PFE Position: Q2 2026 in Review

Huntleigh Advisors increased its Pfizer (PFE) stake by 2.1% in Q2 2026, buying an estimated $35.3K and bringing the position to 66,578 shares worth $1.6M. The position accounts for 0.22% of the portfolio, ranked #99.

Huntleigh Advisors first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.83M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Huntleigh Advisors held 66,578 shares of Pfizer worth $1.6M as of Q2 2026.
  • Huntleigh Advisors bought 1,351 Pfizer shares in Q2 2026, an estimated $35.3K.
  • Pfizer made up 0.22% of Huntleigh Advisors's portfolio in Q2 2026, its #99 holding.
  • Huntleigh Advisors first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Huntleigh Advisors's Pfizer position peaked at $1.83M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.